Atlas Trials

A Study of Subcutaneous Doses of HIP2B in Healthy Male Subjects

Clinical trial NCT01638611 · COMPLETED

Trial details

NCT number
NCT01638611
Sponsor
CureDM
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2012-07-01
Primary completion
2012-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.